Keywords
systemic lupus erythematosus
microangiopathic hemolytic anemia
ADAMTS13
immunosuppressants
How to Cite
Abstract
Thrombotic thrombocytopenic purpura (TTP) is a rare, potentially fatal blood disorder that can be challenging for clinicians to identify in the setting of autoimmune diseases such as systemic lupus erythematosus (SLE). SLE can present with thrombotic microangiopathy (TMA) and differentiation between the two diseases can be quite difficult.
In this case report we present a 62-year-old female with a history of SLE who was hospitalized with thrombocytopenia, dysarthria, dizziness, paresthesia and altered mental status. The laboratory results revealed direct Coombs negative hemolytic anemia, severe thrombocytopenia, significant elevation of lactate dehydrogenase, leukocytosis and presence of few schistocytes in the peripheral film. In addition, we also present evidence for circulating anti-ADAMTS13 antibody/ADAMTS13 antigen. Based on clinical, hematological, and biochemical findings, we concluded that it was a case of TTP-like microangiopathy associated with SLE and indicated treatment with methylprednisolone pulses and plasmapheresis. Later on, she developed psychosis and made plasmapheresis difficult to perform. We continued corticosteroids (dose 1mg/kg), RhoGAM, Chloroquine and Azathioprine, obtaining a satisfactory response after one week of treatment.
References
Knobl P. Thrombotic thrombocytopenic purpura. Memo. 2018; 11(3): 220-226.
Lansigan F, Isufi I, Tagoe CE. Microangiopathic haemolytic anaemia resembling thrombotic thrombocytopenic purpura in systemic lupus erythematosus: the role of ADAMTS13. Rheumatology (Oxford, England). 2011; 50(5): 824-829.
Rare disease database. https://rarediseases.org/rare-dis-eases/thrombotic-thrombocytopenic-purpura/ .National Or-ganization for Rare Disorders (NORD)
James N. George: How I treat patients with thrombotic thrombocytopenic purpura: 2010 Blood (2010) 116 (20): 4060-4069. https://doi.org/10.1182/blood-2010-07-271445
Abu-Hishmeh M, Sattar A, Zarlasht F, et al. Systemic Lupus Erythematosus Presenting as Refractory Thrombotic Throm-bocytopenic Purpura: A Diagnostic and Management Chal-lenge. A Case Report and Concise Review of the Literature. Am J Case Rep. 2016; 17: 782-787.
Mariotte E, Azoulay E, Galicier L, et al. French Reference Center for Thrombotic Microangiopathies. Epidemiology and pathophysiology of adulthood-onset thrombotic micro-angiopathy with severe ADAMTS13 deficiency (thrombotic thrombocytopenic purpura): a cross-sectional analysis of the French national registry for thrombotic microangiopathy. Lancet Haematol 2016;3:e237-45.
Blombery P, Kivivali L, Pepperell D, et al. TTP registry steering committee. Diagnosis and management of thrombotic thrombocytopenic purpura (TTP) in Australia: findings from the first 5 years of the Australian TTP/thrombotic microangi-opathy registry. Intern Med J 2016;46:71-9.
Nesher G, Hanna VE, Moore TL, et al. Thrombotic microangiographic hemolytic anemia in systemic lupus erythematosus. Semin Arthritis Rheum 1994; 24:165-72.
Musio F, Bohen EM, Yuan CM, et al. Review of thrombotic thrombocytopenic purpura in the setting of systemic lupus erythematosus. Semin Arthritis Rheum 1998; 28:1-19.
James N, George MD. Thrombotic Thrombocytopenic Purpura. May 4, 2006 N Engl J Med 2006; 354:1927-1935.
Lansigan F, Isufi I, Tagoe CE. Microangiopathichaemolyticanaemia resembling thrombotic thrombocytopenic purpura in systemic lupus erythematosus: the role of ADAMTS13. Rheumatology (Oxford) 2011;50:824-9.
Jang MJ, Chong SY, Kim IH et al. Clinical features of severe acquired ADAMTS13 deficiency in thrombotic thrombocytopenic purpura: the Korean TTP registry experience. Int J Hematol 2011;93:163-9.
Fujimura Y, Matsumoto M. Registry of 919 patients with thrombotic microangiopathies across Japan: database of Nara Medical University during 1998-2008. Intern Med 2010;49:7-15.
Hassan, Ali Taha A, Mahmoud Ibrahim Yousef Elbadry, and Mohammad Adel Tawfik. A Case Report of Thrombotic Thrombocytopenic Purpura Associated with Systemic Lupus Erythematosus: Overlapping Features. Am J Med Case Re-ports 2.10 (2014): 206-213.
Abu-Hishmeh M, Sattar A, Zarlasht F, et al. Systemic lupus erythematosus presenting as refractory thrombotic thrombo-cytopenic purpura: a diagnostic and management challenge. A case report and concise review of the literature. Am J Case Rep. 2016;17:782-787.
Liang Sj, Zheng Qy, Li MS et al. Response to belimumab in thrombotic thrombocytopenic purpura associated with systemic lupus erythematosus: a case-based review. Clin Rheumatol 2022,41, 2561–2569.
Chen J, Jin JX, Xu XF et al. Successful treatment of plasma exchange-refractory thrombotic thrombocytopenic purpura with rituximab: A case report. World J Clin Cases. 2020 Jun 26;8(12):2617-2622.
This work is licensed under a Creative Commons Attribution 4.0 International License.